Shenghua Shi

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Plexxikon Inc., Novo Nordisk A/s, Noro Nordisk A/s. Active years: 2003-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shenghua Shi. Retrieved from https://idiyas.com/inventor/shenghua-shi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 80.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 2)

Average Co-Inventor Count = 11.1

ph-index = 10

Forward Citations = 672(Granted Patents)

Company Filing History:

Years Active: 2003-2013

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8470818 - Compounds and methods for kinase modulation, and indications therefor (2013-06-25),

2. 8415469 - Compounds and methods for kinase modulation, and indications therefor (2013-04-09),

3. 8268858 - Compounds and methods for kinase modulation, and indications therefor (2012-09-18),

4. 8053463 - PPAR active compounds (2011-11-08),

5. 7863289 - Compounds and methods for kinase modulation, and indications therefor (2011-01-04),

6. 7863288 - Compounds and methods for kinase modulation, and indications therefor (2011-01-04),

7. 7531568 - PPAR active compounds (2009-05-12),

8. 6875760 - Glucagon antagonists/inverse agonists (2005-04-05),

9. 6613942 - Glucagon antagonists/inverse agonists (2003-09-02),

10. 6503949 - Glucagon antagonists/inverse agonists (2003-01-07),

Title: Inventor Profile: Shenghua Shi

Introduction

Shenghua Shi is a prolific inventor based in San Diego, California, known for his significant contributions to the field of biotechnology and pharmacology. With a total of 10 patents to his name, he is focused on developing innovative compounds and methods that target protein kinases to treat various diseases.

Latest Patents

Among his latest innovations are two key patents titled "Compounds and Methods for Kinase Modulation, and Indications Therefor." These patents describe compounds that exhibit activity on protein kinases, as well as methods for utilizing such compounds to treat conditions characterized by abnormal protein kinase activity. This research holds promise for addressing numerous health issues related to kinase dysfunction.

Career Highlights

Shenghua Shi has had a remarkable career, working with renowned companies such as Plexxikon Inc. and Novo Nordisk A/S. His experience in these prominent organizations has allowed him to refine his expertise in drug discovery and development, particularly in the realm of targeted therapies.

Collaborations

Throughout his career, Shenghua has collaborated with fellow researchers including Prabha N. Ibrahim and Dean R. Artis. These partnerships have furthered his research endeavors and contributed to the successful development of his patented compounds.

Conclusion

In summary, Shenghua Shi is a distinguished inventor whose innovative work in kinase modulation is paving the way for new therapeutic options in medicine. His dedication to advancing biotechnology highlights the importance of collaboration and intellectual property in driving innovation forward.

Profile summary based on public USPTO records.